SPOTLIGHT -
Ingrezza Sprinkle Capsules Received FDA Approval for Tardive Dyskinesia in Adults
The new formulation was approved to help patients with tardive dyskinesia who have trouble swallowing.
Brexpiprazole + Sertraline Combination for PTSD Submitted for sNDA Review
A supplemental new drug application was submitted for the combination of brexpiprazole and sertraline in the treatment of PTSD in adults.
Landmark Study Highlights Efficacy of MDMA-Assisted Therapy for PTSD
In a first of its kind study, MDMA-assisted therapy successfully supported patients with PTSD.
Annual Conference Highlights New Research, Advances in ADHD
In an exclusive interview, APSARD President Elect Greg Mattingly, MD, tells Psychiatric Times readers what they can expect at this year's meeting.
Looking to the Future of Mood Disorders Treatment
Psychiatric Times chats with new Mood Disorders Section Editor Gus Alva, MD, about his new role, his interest in mood disorders, and his love of psychiatry.
Insights and Highlights From the Annual Psychiatric Times World CME Conference
Did you miss the 2023 Annual Psychiatric Times World CME Conference? Don't worry, we've got you covered.
Preliminary Phase 2 Data Shows Psilocybin for PTSD Is Well-Tolerated
Initial data from phase 2 safety profile for psilocybin in the treatment of PTSD indicates the treatment is well-tolerated.
Remember and Commit: 2023 World AIDS Day
2023 World AIDS Day looks to remember those who have been lost and a renewed commitment to supporting patients with HIV/AIDS.
To BD or Not to Diagnose BD: That's the Question
What are some key considerations in diagnosing bipolar disorder? Joseph F. Goldberg, MD, shares insights at the recent 2023 Annual Psychiatric Times World CME Conference.
Beyond Benzos: Treatment Options for Insomnia
What are the treatment options for insomnia when avoiding benzodiazepines? John W. Winkelman MD, PhD, shares insights and guidance at the 2023 Annual Psychiatric Times World CME Conference.
Orexin: The New Kid on the Insomnia Block
The newest class of medications to treat insomnia have many advantages.
Pioneering Change in Juvenile Correctional Psychiatry
Elizabeth Lowenhaupt, MD, CCHP, shares her insights and experiences on correctional psychiatry and juvenile mental health as she looks toward the future of the field.
FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD
Following a long path to approval, gepirone hydrochloride extended-release tablets (Exxua) is the first FDA-approved medication with this novel mechanism of action for adults with MDD.
Sleep Research Roundup: August 18
What's new in sleep research?
Phase 3 Study Finds Subcutaneous Ketamine Safe and Effective in TRD
In the largest study of its kind to date, researchers found promising results for subcutaneous ketamine for treatment resistant depression.
New Research, Treatment Issues Featured at Annual Meeting
Did you miss our APA Annual Meeting coverage?
Poster Highlights Racial/Ethnic Disparities in LAI Use
Data presents opportunities to enhance care and improve treatment adherence.
Poster Examines Accuracy of DID Information on TikTok, YouTube
Poster presented at the 2023 American Psychiatric Association Annual Meeting highlights the good and bad of social media information.
Leveraging Alliance-Based Interventions to Address Suicide Risk
Session at the 2023 Annual Meeting provides framework for addressing suicidal ideation.
Meeting Poster Explores New Onset Psychosis in COVID-19
Research explores the differences between new-onset psychosis in patients with infection versus healthy controls.
Multidisciplinary Program Improves Perinatal Depressive Symptoms
Study results presented at the 2023 American Psychiatric Association Annual Meeting.
The Importance of Evolutionary Psychiatry Explored at Annual Meeting
Leveraging evolutionary psychiatry may help clinicians and patients alike.
Addressing Narcolepsy: Approaches and Advances
MDD: Test Your Knowledge
Test your knowledge on issues in major depressive disorder.
Culturally Sensitive Adherence Scale Shows Promise
First of its kind culturally sensitive adherence scale factors in CVD risk factors to find ways to best support patients.
Spotlight on Neurostimulation: Research Innovation Award
Innovation award presented to early career psychiatrist promotes exploration and research in the use of neurostimulation for psychiatric disorders.
Addressing Unmet Needs and Clinical Challenges in MDD
Here are 9 things you need to know about the clinical management of major depressive disorder.
Individualizing Treatment Options in BDI
“The sooner you can recognize and diagnose bipolar, the sooner you can institute effective evidence-based treatments.”
Beyond Counting Sheep: Helping Patients With Insomnia
Many individuals do not get medical support for insomnia. Here's how you can help.
Psychopharmacology Conference Offers New Research, Prescribing Tips
Check out the best clinical pearls from the 2022 Neuroscience Education Institute (NEI) Congress!